IL1B and cancer: Our work provides the first demonstration of a complex crosstalk between cancer-specific bcl-2 and TAM, through the involvement of NF-κB and identifies IL-1β as central player of the bcl-2-driven protumor reprogramming of macrophages, as well as orchestrator of the functional crosstalk between cancer and immune cells.